India Faces Uphill Battle in Achieving TB-Free Status by 2025
While the Indian government had set an ambitious target of making India tuberculosis (TB)-free by 2025, a new study paints a grim picture of the challenges ahead. Researchers predict that between 2021 and 2040, India will witness over 62.4 million TB cases and at least 8.1 million deaths due to TB bacilli. The economic repercussions could be severe, with a projected cumulative GDP loss of over $146 billion US dollars.
Published in PLoS Medicine, the study emphasizes the urgent need for increased investment in TB research and development to combat the escalating crisis.
The United Nations’ Sustainable Development Goals aim to reduce TB deaths by 90% by 2030, but current funding falls short of the required levels. Detecting new TB cases and improving treatment are crucial steps in curbing the spread of the disease, with enhanced diagnosis showing promise in outperforming the development of new drugs.
According to the Stop TB Partnership, global investments in new TB diagnostics, drugs, and vaccines remain below optimal levels, with only $0.9 billion out of the $2 billion target allocated in 2020. Given that India accounts for 28% of the global TB burden, the country’s share of necessary investments is vital for progress.
The researchers emphasize the importance of implementing improved treatment interventions and expanding TB detection rates to mitigate the impact of the disease. By investing in these strategies, India could potentially avert millions of TB cases and fatalities, paving the way towards a healthier, TB-free future.